- Home
- EVOK vs PRPO Comparison
EVOK vs PRPO Comparison
Compare EVOK & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- PRPO
- Stock Information
- Founded
- EVOK 2007
- PRPO N/A
- Country
- EVOK United States
- PRPO United States
- Employees
- EVOK N/A
- PRPO N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- EVOK Health Care
- PRPO Industrials
- Exchange
- EVOK Nasdaq
- PRPO Nasdaq
- Market Cap
- EVOK 4.2M
- PRPO N/A
- IPO Year
- EVOK 2013
- PRPO N/A
- Fundamental
- Price
- EVOK $2.66
- PRPO $11.18
- Analyst Decision
- EVOK
- PRPO
- Analyst Count
- EVOK 0
- PRPO 0
- Target Price
- EVOK N/A
- PRPO N/A
- AVG Volume (30 Days)
- EVOK 19.4K
- PRPO 9.8K
- Earning Date
- EVOK 08-12-2025
- PRPO 08-12-2025
- Dividend Yield
- EVOK N/A
- PRPO N/A
- EPS Growth
- EVOK N/A
- PRPO N/A
- EPS
- EVOK N/A
- PRPO N/A
- Revenue
- EVOK $11,594,083.00
- PRPO $20,029,000.00
- Revenue This Year
- EVOK $57.82
- PRPO N/A
- Revenue Next Year
- EVOK $59.12
- PRPO N/A
- P/E Ratio
- EVOK N/A
- PRPO N/A
- Revenue Growth
- EVOK 89.89
- PRPO 26.67
- 52 Week Low
- EVOK $1.94
- PRPO $3.90
- 52 Week High
- EVOK $12.32
- PRPO $11.80
- Technical
- Relative Strength Index (RSI)
- EVOK 40.87
- PRPO 58.62
- Support Level
- EVOK $2.50
- PRPO $10.82
- Resistance Level
- EVOK $2.84
- PRPO $11.70
- Average True Range (ATR)
- EVOK 0.22
- PRPO 0.57
- MACD
- EVOK -0.03
- PRPO -0.15
- Stochastic Oscillator
- EVOK 31.75
- PRPO 52.31
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.